Table 1 Histopathologic characteristics, familial history and the status of multivitamin use among BBD patients in placebo (n = 40) and intervention (n = 40) groups at baseline of the study
Characteristics | Intervention (n = 40) | Placebo (n = 40) | p-valuea |
|---|---|---|---|
Histopathological characteristics | |||
Fibrocystic | 34(85.0) b | 35(87.5) | < 0.001 |
Fibroadenoma | 6(15.0) | 5(12.5) | |
Family history of BC | |||
No | 35(87.5) | 30(75.0) | < 0.001 |
Positive | 5(12.5) | 10(25.0) | |
Family history of BBD | |||
No | 40(100.0) | 39(97.5) | < 0.001 |
Positive | 0 | 1(2.5) | |
Smoker | |||
Never | 40(100) | 40(100) | N/A |
Ever | 0 | 0 | |
Current | 0 | 0 | |
Multivitamin use | |||
No | 38(95.0) | 35(87.5) | < 0.001 |
Yes | 2(5.0) | 5(12.5) | |